Author:
Vorobeva Olga V.,Gimaldinova Natalya E.,Romanova L. P.
Abstract
COVID-19 is a highly transmissible disease with severe course especially in patients with nephrogenic hypertensive disease and chronic kidney disease due to a higher incidence of all-type infections than in the general population. The aim of the study is to describe a clinical case of SARS-CoV-2 infection complicated by nephrogenic pulmonary edema and COVID-associated pneumonitis, alveolitis. Description of the case. Patient K.S., born in 1975, was hospitalized 24 hours after symptom onset at emergency hospital due to complaints of increased blood pressure up to 180200/110120 mm Hg, temperature up to 38.7C, dry cough, feeling of heaviness in the chest, change in urine color. PCR smear for SARS-CoV-2 was positive. Computed tomography revealed a pattern of bilateral COVID-associated pneumonitis, alveolitis, with 75% involvement. The electrocardiogram revealed signs of left ventricular myocardial hypertrophy. Ultrasound examination showed numerous cysts in the kidneys. Urinalysis at admission: leukocytes 499, erythrocytes 386. Glomerular filtration rate (CKD-EPI: 29 ml/min/1.73 m2) and corresponds to stage IV of chronic kidney disease. Coagulogram: fibrinogen: 32.3 (1.64.0) g/l, D-dimer: 663 (0250). Despite the treatment, the patients condition worsened, the phenomena of cardiopulmonary and renal insufficiency increased, which led to a fatal outcome. During a virological study of sectional material: SARS-CoV-2 coronavirus RNA was found in the lung and kidneys. Signs of bilateral COVID-associated pneumonitis, alveolitis with diffuse cellular infiltrates in combination with changes in the alveolar apparatus, signs of pulmonary edema were revealed. Heart-related signs swelling of the interstitium, fragmented muscle fibers, some of them hypertrophied, a wave-like deformation of cardiomyocytes, blurring of the transverse striation. Arteries with thickened sclerosed walls. In the kidneys diffuse damage to the proximal tubules of the nephron with areas of cortical and proximal necronephrosis, areas of fibrinoid swelling. Conclusion. The cause of death of a 45-year-old patient was a severe course of bilateral COVID-associated pneumonitis, alveolitis, which contributed to the development of renal medullary hypoxia and type 1 cardiorenal syndrome, which led to early nephrogenic pulmonary edema.
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Reference14 articles.
1. Бикбов Б.Т., Томилина Н.А. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998–2007 г. (аналитический отчет по данным Российского регистра заместительной почечной терапии) // Нефрология и диализ. 2009. Т. 11, № 3. С. 144–233. [Bikbov B.T., Tomilina N.A. Status of renal replacement therapy in ESRD patients of Russian Federation in 1998–2007 (analytic report of Russian RRT Register). Nefrologiya i dializ = Nephrology and Dialysis, 2009, vol. 11, no. 3, pp. 144–233. (In Russ.)]
2. Changes in the brain, lungs and heart with COVID-19 against the background of cerebrovascular pathology
3. Acute myocardial infarction and coronavirus infection (COVID-19)
4. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 15 от 22.02.2022. М., 2022. 233 с. [Interim guidelines. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 15 dated 22.02.2022. Moscow, 2022. 233 p. (In Russ.)]
5. Клинические рекомендации. Хроническая болезнь почек (ХБП). Кодирование по Международной статистической классификации болезней и проблем, связанных со здоровьем: N18.1/N18.2/N18.3/N18.4/N18.5/N18.9 с кодами осложнений и ассоциированных состояний (при наличии) Z49.0/Z49.1/Z49.2/D63.8*/E87.2/E87.5/E21.1/Е83.3/E83.5/Е83.8/N25.0/E89.2 Возрастная группа: взрослые. Год утверждения: 2021 (пересмотр каждые 3 года). Разработчик клинической рекомендации: Ассоциация нефрологов. 231 с. [Clinical guidelines. Chronic kidney disease (CKD). International Statistical Classification of Diseases and Related Health Problems coding: N18.1/N18.2/N18.3/N18.4/N18.5/N18.9 with codes for complications and associated conditions (if any) Z49.0/Z49.1/Z49.2/D63.8*/E87.2/E87.5/E21.1/Е83.3/E83.5/Е83.8/N25.0/E89.2 Age group: adults Approved year: 2021 (revised every 3 years). Clinical guideline developer: Association of Nephrologists. 231 p. (In Russ.)]